(A Top Pick Oct 27/16. Up 4%.) Sold this a while ago. Felt there was a lot more competition on the clothing side, and they were losing share there.
Movies have had a difficult time of late. They’ve had a very bad summer season for blockbusters. People are not as eager to go to movie theatres unless there is something really, really important they want to see. The company has done a very good job with concessions. He would wait for another quarter or so before looking at this.
Movies have had a difficult time of late. They’ve had a very bad summer season for blockbusters. People are not as eager to go to movie theatres unless there is something really, really important they want to see. The company has done a very good job with concessions. He would wait for another quarter or so before looking at this.
He likes this. It is not expensive and pays a decent dividend. A couple of things have happened that has hurt. Other companies cut back on fixed income, currency and commodity (FCC) side of the business because it is a very highly intensive capital business from a regulatory point of view. Goldman decided not to do that as much. They are still #1 in cash equities, etc.
He likes this. It is not expensive and pays a decent dividend. A couple of things have happened that has hurt. Other companies cut back on fixed income, currency and commodity (FCC) side of the business because it is a very highly intensive capital business from a regulatory point of view. Goldman decided not to do that as much. They are still #1 in cash equities, etc.
People think of this as a credit card, but it really is a toll road. They get paid every time someone uses a visa card. There have been very few pullbacks where you can buy the stock. The one slight risk to these companies is that a lot of times the payment side is being disintermediated globally with new FinTech technology. Nevertheless, this has been a great story.
People think of this as a credit card, but it really is a toll road. They get paid every time someone uses a visa card. There have been very few pullbacks where you can buy the stock. The one slight risk to these companies is that a lot of times the payment side is being disintermediated globally with new FinTech technology. Nevertheless, this has been a great story.
One of the premier oil companies in Canada. They are very astute at making acquisitions and integrating them, and have made a bunch in the last little while. Also, every time they have worked on a project through the years, they have always been on time. At this level, this should be okay.
The trouble with these kind of drug companies is that they made lots of acquisitions, which is how they have grown. Many were considered growth companies because they came out with social drugs, and ended up with huge multiples. There are lots of good things in their pipeline, but there are not going to be these massive, massive blockbuster drugs they used to have.
The trouble with these kind of drug companies is that they made lots of acquisitions, which is how they have grown. Many were considered growth companies because they came out with social drugs, and ended up with huge multiples. There are lots of good things in their pipeline, but there are not going to be these massive, massive blockbuster drugs they used to have.
Not the kind of stock he would buy, because the valuation doesn’t work for. They have 52 million US subscribers and 52 million international subscribers. They have a great brand and are way ahead of everybody else, and are developing their own products. He can see them having great pricing power over the next little while because of their strong brand. Thinks there is still a lot of growth to the story.
Not the kind of stock he would buy, because the valuation doesn’t work for. They have 52 million US subscribers and 52 million international subscribers. They have a great brand and are way ahead of everybody else, and are developing their own products. He can see them having great pricing power over the next little while because of their strong brand. Thinks there is still a lot of growth to the story.